{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:35Z","timestamp":1792806035654,"version":"4.5.0"},"reference-count":22,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,7,18]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Coronary artery bypass grafting (CABG) is an established revascularisation strategy for multivessel and left main coronary artery disease. Although aspirin is routinely recommended for patients with CABG, the optimal antiplatelet regimen after CABG remains unclear. We evaluated the efficacies and risks of different antiplatelet regimens (dual (DAPT) versus single (SAPT), and dual with clopidogrel (DAPT-C) versus dual with ticagrelor or prasugrel (DAPT-T\/P)) after CABG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and performed a comprehensive literature search using PubMed, Ovid Medline, Ovid Embase and Cochrane Central Register of Controlled Trials. Data were extracted and pooled using random-effects models and Review Manager (V.5.4).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the 2970 article abstracts screened, 215 full-text articles were reviewed and 38 studies totaling 77 447 CABG patients were included for analyses. DAPT compared with SAPT was associated with significantly lower all-cause mortality (OR 0.65 with 95% CI 0.50 to 0.86; p=0.002), cardiovascular mortality (OR 0.53, 95% CI 0.33 to 0.84; p=0.008), and major adverse cardiac and cerebrovascular events (MACCE) (OR 0.68, 95% CI 0.51 to 0.91; p=0.01), but higher rates of major (OR 1.30, 95% CI 1.08 to 1.56; p=0.007) and minor bleeding (OR 1.87, 95% CI 1.28 to 2.74; p=0.001) after CABG. DAPT-T\/P compared with DAPT-C was associated with significantly lower all-cause (OR 0.43, 95% CI 0.29 to 0.65; p\u22640.0001) and cardiovascular mortality (OR 0.44, 95% CI 0.24 to 0.80; p=0.008), and no differences on other cardiovascular or bleeding outcomes after CABG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In patients with CABG, DAPT compared with SAPT and DAPT-T\/P compared with DAPT-C were associated with reduction in all-cause and cardiovascular mortality, especially in patients with acute coronary syndrome. Additionally, DAPT was associated with reduction in MACCE, but higher rates of major and minor bleeding. An individualised approach to choosing antiplatelet regimen is necessary for patients with CABG based on ischaemic and bleeding risks.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323097","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T13:20:15Z","timestamp":1693401615000},"page":"323-330","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-6667","authenticated-orcid":false,"given":"Ankit","family":"Agrawal","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Majid","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamah","family":"Badwan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aro Daniela","family":"Arockiam","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8480-3745","authenticated-orcid":false,"given":"Joseph","family":"El Dahdah","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alveena B","family":"Syed","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Schleicher","sequence":"additional","affiliation":[{"name":"Floyd D. Loop Alumni Library, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant W","family":"Reed","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C","family":"Cremer","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-9402","authenticated-orcid":false,"given":"Tom Kai Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"2025092002195889000_110.5.323.1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025092002195889000_110.5.323.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"2025092002195889000_110.5.323.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.19.2446"},{"key":"2025092002195889000_110.5.323.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040982"},{"key":"2025092002195889000_110.5.323.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.978007"},{"key":"2025092002195889000_110.5.323.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.10.008"},{"key":"2025092002195889000_110.5.323.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"2025092002195889000_110.5.323.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.029"},{"key":"2025092002195889000_110.5.323.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"2025092002195889000_110.5.323.10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jtcvs.2017.09.092","article-title":"Pattern and predictors of dual antiplatelet use after coronary artery bypass graft surgery","volume":"155","author":"Mori","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025092002195889000_110.5.323.11","first-page":"100","article-title":"Contemporary audit of antiplatelet therapy prescribing patterns following coronary artery bypass grafting","volume":"132","author":"Wei","year":"2019","journal-title":"N Z Med J"},{"key":"2025092002195889000_110.5.323.12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.2022.11966","article-title":"Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery: a systematic review and meta-analysis","volume":"328","author":"Sandner","year":"2022","journal-title":"JAMA"},{"key":"2025092002195889000_110.5.323.13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2018.07.083","article-title":"Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: an updated meta-analysis","volume":"269","author":"Cardoso","year":"2018","journal-title":"Int J Cardiol"},{"key":"2025092002195889000_110.5.323.14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjcard.2017.09.022","article-title":"Meta-analysis of aspirin versus dual antiplatelet therapy following coronary artery bypass grafting","volume":"121","author":"Agarwal","year":"2018","journal-title":"Am J Cardiol"},{"key":"2025092002195889000_110.5.323.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"2025092002195889000_110.5.323.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"2025092002195889000_110.5.323.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005874"},{"key":"2025092002195889000_110.5.323.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908973"},{"key":"2025092002195889000_110.5.323.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38985.646481.55"},{"key":"2025092002195889000_110.5.323.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3775"},{"key":"2025092002195889000_110.5.323.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.828541"},{"key":"2025092002195889000_110.5.323.22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:20:07Z","timestamp":1758360007000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,2,12]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/heartjnl-2023-323097"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323097","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]}}}